Compared to placebo, there was a barely statistically significant 15% prolongation in the t 1⁄2 of montelukast and 18% increase in the M1:montelukast AUC 0‐∞ ratio in the prasugrel phase.
← all excerpts
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.
1
—
—